🇺🇸 FDA
Patent

US 8921358

Apoptosis signal-regulating kinase 1 inhibitors

granted A61KA61K31/519A61P

Quick answer

US patent 8921358 (Apoptosis signal-regulating kinase 1 inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/519, A61P, A61P1/00, A61P1/04